ACTU

ACTUATE THERAPEUTICS, INC. (ticker: ACTU) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of ACTU's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. ACTU reported no tagged revenue in revenue and -$5.63M for the period ending 2026-03-31, with operating cash flow of -$5.02M. Cash and equivalents stood at $8.13M (up 109.1% year-over-year). Total assets of $8.91M exceed total liabilities of $5.13M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.